Personal information

No personal information available

Activities

Employment (1)

Design Therapeutics: Carlsbad, California, US

(R&D)
Employment
Source: Self-asserted source
Jarod Waybright

Works (3)

Cdyl Deficiency Brakes Neuronal Excitability and Nociception through Promoting Kcnb1 Transcription in Peripheral Sensory Neurons.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2022-02 | Journal article
Contributors: Sun ZW; Waybright JM; Beldar S; Chen L; Foley CA; Norris-Drouin JL; Lyu TJ; Dong A; Min J; Wang YP et al.
Source: Self-asserted source
Jarod Waybright via Europe PubMed Central

Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins

ACS Omega
2022-01-11 | Journal article
Contributors: Kelsey N. Lamb; Sarah N. Dishman; Jarod M. Waybright; Isabelle A. Engelberg; Justin M. Rectenwald; Jacqueline L. Norris-Drouin; Stephanie H. Cholensky; Kenneth H. Pearce; Lindsey I. James; Stephen V. Frye
Source: check_circle
Crossref

A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2’s Association with the HUSH Complex

ACS Chemical Biology
2021-09-17 | Journal article
Contributors: Jarod M. Waybright; Sarah E. Clinkscales; Kimberly D. Barnash; Gabrielle R. Budziszewski; Justin M. Rectenwald; Anna M. Chiarella; Jacqueline L. Norris-Drouin; Stephanie H. Cholensky; Kenneth H. Pearce; Laura E. Herring et al.
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for ACS medicinal chemistry letters. (1)